Estrogen therapy linked to lower Alzheimer’s risk, Stanford study finds
NEWYou can now listen to Fox News articles! Women who used estrogen-only menopausal hormone therapy (MHT) were less likely to develop Alzheimer’s-related brain changes or dementia, according to a large Stanford study published Aug. 12 in Neurology. The…
Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trials
An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday. Gantenerumab is part of a class of injected drugs that are…